Genomic Medicine Program Advisory Committee; Notice of Meeting, 10370 [2016-04283]

Download as PDF 10370 Federal Register / Vol. 81, No. 39 / Monday, February 29, 2016 / Notices is mandated by Congress to investigate, assess, and report to Congress annually on ‘‘the national security implications of the economic relationship between the United States and the People’s Republic of China.’’ Pursuant to this mandate, the Commission will hold a public hearing in Washington, DC on Thursday, March 10, 2016, on ‘‘China-South Asia Relations.’’ Background: This is the third public hearing the Commission will hold during its 2016 report cycle to collect input from academic and industry experts concerning the national security implications of China’s military modernization efforts for the United States. The hearing will explore the economic, geopolitical, and security elements of China’s South Asia strategy, and examine in detail China’s relations with India and Pakistan in particular. In addition, the hearing will assess how China’s evolving engagement in the region impacts U.S. interests. The hearing will be co-chaired by Chairman Dennis Shea and Commissioner Katherine Tobin, Ph.D. Any interested party may file a written statement by March 10, 2016, by mailing to the contact below. A portion of each panel will include a question and answer period between the Commissioners and the witnesses. Location, Date and Time: Room: TBD. Thursday, March 10, 2016, start time is 9:00 a.m. A detailed agenda for the hearing will be posted to the Commission’s Web site at www.uscc.gov. Also, please check our Web site for possible changes to the hearing schedule. Reservations are not required to attend the hearing. [FR Doc. 2016–04339 Filed 2–26–16; 8:45 am] BILLING CODE 1137–00–P DEPARTMENT OF VETERANS AFFAIRS Geriatrics and Gerontology Advisory Committee; Notice of Meeting Authority: Congress created the U.S.China Economic and Security Review Commission in 2000 in the National Defense Authorization Act (Pub. L. 106–398), as amended by Division P of the Consolidated Appropriations Resolution, 2003 (Pub. L. 108–7), as amended by Public Law 109–108 (November 22, 2005), as amended by Public Law 113–291 (December 19, 2014). VerDate Sep<11>2014 19:23 Feb 26, 2016 Jkt 238001 The Department of Veterans Affairs (VA) gives notice under the Federal Advisory Committee Act, 5 U.S.C. App. 2, that the Genomic Medicine Program Advisory Committee will meet on April 12, 2016, at the U.S. Access Board, 1331 F Street NW., Suite 1000, Washington, DC 20004. The meeting will convene at 9:00 a.m. and adjourn at 5:00 p.m. The meeting is open to the public. The purpose of the Committee is to provide advice and make recommendations to the Secretary of Veterans Affairs on using genetic information to optimize medical care for Veterans and to enhance development of tests and treatments for diseases particularly relevant to Veterans. The Committee will receive program updates and continue to provide insight into optimal ways for VA to incorporate genomic information into its health care program while applying appropriate ethical oversight and protecting the privacy of Veterans. The meeting focus will be on interagency collaborations, development of IT and informatics infrastructure, quality control of genomic data, and data access for the Million Veteran Program. The Committee will also receive an update from the Clinical Genomics Service. Public comments will be received at 3:30 p.m. and are limited to 5 minutes each. Individuals who speak are invited to submit a 1–2 page summary of their comments for inclusion in the official meeting record to Dr. Sumitra Muralidhar, Designated Federal Officer, 810 Vermont Avenue NW., Washington, DC 20420, or by email at sumitra.muralidhar@va.gov. Any member of the public seeking additional information should contact Dr. Muralidhar at (202) 443–5679. The Department of Veterans Affairs (VA) gives notice under the Federal Advisory Committee Act, 5 U.S.C. App. 2, that a meeting of the Geriatrics and Gerontology Advisory Committee will be held on April 19–20, 2016, in Room 730 at the Department of Veterans Affairs, 810 Vermont Avenue NW., Washington, DC. On April 29, the session will begin at 8:30 a.m. and end at 5 p.m. On April 20, the session will begin at 8 a.m. and end at 12 noon. This meeting is open to the public. The purpose of the Committee is to provide advice to the Secretary of VA and the Under Secretary for Health on all matters pertaining to geriatrics and gerontology. The Committee assesses the capability of VA health care facilities and programs to meet the medical, psychological, and social needs of older Veterans and evaluates VA programs designated as Geriatric Research, Education, and Clinical Centers. The meeting will feature presentations and discussions on VA’s geriatrics and extended care programs, aging research activities, updates on VA’s employee staff working in the area of geriatrics (to include training, recruitment and retention approaches), Veterans Health Administration (VHA) strategic planning activities in geriatrics and extended care, recent VHA efforts regarding dementia and program advances in palliative care, and performance and oversight of VA Geriatric Research, Education, and Clinical Centers. No time will be allocated at this meeting for receiving oral presentations from the public. Interested parties should provide written comments for review by the Committee to Mrs. Marcia Holt-Delaney, Program Analyst, Geriatrics and Extended Care Services (10P4G), Department of Veterans Affairs, 810 Vermont Avenue NW., Washington, DC 20420, or via email at Marcia.Holt-Delaney@va.gov. Individuals who wish to attend the meeting should contact Mrs. HoltDelaney at (202) 461–6769. By Direction of the Secretary: Rebecca Schiller, Advisory Committee Management Officer. Dated: February 24, 2016. Rebecca Schiller, Committee Management Officer. [FR Doc. 2016–04283 Filed 2–26–16; 8:45 am] [FR Doc. 2016–04333 Filed 2–26–16; 8:45 am] BILLING CODE P Any member of the public seeking further information concerning the hearing should contact Anthony DeMarino, 444 North Capitol Street NW., Suite 602, Washington DC 20001; phone: 202–624– 1496, or via email at ademarino@ uscc.gov. Reservations are not required to attend the hearing. FOR FURTHER INFORMATION CONTACT: asabaliauskas on DSK5VPTVN1PROD with NOTICES Date: February 24, 2016 Michael Danis, Executive Director, U.S.-China Economic and Security Review Commission. BILLING CODE P DEPARTMENT OF VETERANS AFFAIRS Genomic Medicine Program Advisory Committee; Notice of Meeting PO 00000 Frm 00166 Fmt 4703 Sfmt 9990 E:\FR\FM\29FEN1.SGM 29FEN1

Agencies

[Federal Register Volume 81, Number 39 (Monday, February 29, 2016)]
[Notices]
[Page 10370]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-04283]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF VETERANS AFFAIRS


Genomic Medicine Program Advisory Committee; Notice of Meeting

    The Department of Veterans Affairs (VA) gives notice under the 
Federal Advisory Committee Act, 5 U.S.C. App. 2, that the Genomic 
Medicine Program Advisory Committee will meet on April 12, 2016, at the 
U.S. Access Board, 1331 F Street NW., Suite 1000, Washington, DC 20004. 
The meeting will convene at 9:00 a.m. and adjourn at 5:00 p.m. The 
meeting is open to the public.
    The purpose of the Committee is to provide advice and make 
recommendations to the Secretary of Veterans Affairs on using genetic 
information to optimize medical care for Veterans and to enhance 
development of tests and treatments for diseases particularly relevant 
to Veterans.
    The Committee will receive program updates and continue to provide 
insight into optimal ways for VA to incorporate genomic information 
into its health care program while applying appropriate ethical 
oversight and protecting the privacy of Veterans. The meeting focus 
will be on interagency collaborations, development of IT and 
informatics infrastructure, quality control of genomic data, and data 
access for the Million Veteran Program. The Committee will also receive 
an update from the Clinical Genomics Service. Public comments will be 
received at 3:30 p.m. and are limited to 5 minutes each. Individuals 
who speak are invited to submit a 1-2 page summary of their comments 
for inclusion in the official meeting record to Dr. Sumitra Muralidhar, 
Designated Federal Officer, 810 Vermont Avenue NW., Washington, DC 
20420, or by email at sumitra.muralidhar@va.gov. Any member of the 
public seeking additional information should contact Dr. Muralidhar at 
(202) 443-5679.

    By Direction of the Secretary:
Rebecca Schiller,
Advisory Committee Management Officer.
[FR Doc. 2016-04283 Filed 2-26-16; 8:45 am]
 BILLING CODE P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.